HomeFileStructural heart disease

Structural heart disease

View Category

Structural heart disease

Predictors and Evolution of Need for PPM after TAVR with Self-Expanding Valves

In the context of TAVR, one of the current challenges is the need for permanent pacemaker implantation...
solaci -
Learn More
Other

ESC 2023 | BUDAPEST CRT Upgrade trial

Approximately 1 million pacemakers (PM) or Implantable cardioverter-defibrillators (ICDs) are placed every year around the world, and...
solaci -
Learn More
Left Atrial Apendix Closure

Left Atrial Appendage Occlusion: Clinical Outcomes according to Device Implantation Depth

Continuous improvement of left atrial appendage occlusion (LAAO) devices has had a positive impact on the safety...
solaci -
Learn More
Mitral valve

Degenerative Mitral Regurgitation: Impact on Post-Procedural Gradient

Primary or degenerative mitral regurgitation (MR) occurs frequently. Even though surgery continues to be the standard treatment...
solaci -
Learn More
Structural heart disease

MyVal Device in Non-Calcified Severe Aortic Regurgitation

Due to the proven long-term results and substantial increase in the number of transcatheter aortic valve implantation...
solaci -
Learn More
Left Atrial Apendix Closure

Left Atrial Appendage Closure: As Effective in Men and Women?

Atrial fibrillation is the most prevalent arrhythmia and to prevent its potential complications, we should administer anticoagulants...
solaci -
Learn More
Structural heart disease

Predictors and Evolution of Permanent Pacemaker After TAVR with Self-Expanding Valves

Transcatheter aortic valve replacement (TAVR) has shown remarkable benefits and continues to advance towards lower-risk patients and...
solaci -
Learn More
Highlighted Presentations

SOLACI-SBHCI 2023 | TAVI – Minimizing Risks, Optimizing Outcomes & Impact of the Index Procedure on Future Options – Dr. Ole De Backer

Read the most outstanding articles from SOLACI-SBHCI 2023 Congress. In this case, check the presentation by Dr. Ole...
solaci -
Learn More